Johnson & Johnson SURGICAL — Percent Change (as a percent) increased by 29.7% to 40.6% in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 2437.5%, from 1.6% to 40.6%. This is a positive signal — higher values indicate stronger performance for this metric.
A positive percentage indicates segment expansion and strong commercial execution, whereas a negative percentage suggests a contraction in market share or a slowdown in surgical procedure volumes.
This metric measures the period-over-period growth rate of revenue generated by the surgical products segment, expressed...
Comparable to organic or reported segment revenue growth rates disclosed by peers in the medical technology and surgical equipment sectors.
jnj_segment_surgical_percent_change_as_a_percent| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 38.9% | 67% | 23.5% | 61.1% | 29.2% | -9.7% | -2.6% | 26.8% | -1.2% | -4.2% | 1.6% | 10.1% | 11.4% | 31.3% | 40.6% |
| QoQ Change | — | +72.2% | -64.9% | +160.0% | -52.2% | -133.2% | +73.2% | >999% | -104.5% | -250.0% | +138.1% | +531.3% | +12.9% | +174.6% | +29.7% |
| YoY Change | — | — | — | +57.1% | — | -114.5% | -104.3% | -8.2% | — | -61.5% | -94.0% | — | >999% | +845.2% | >999% |
We use cookies for analytics. See our Privacy and Cookie Policy.